We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.35B
AUM Growth
+$162M
Cap. Flow
+$9.89M
Cap. Flow %
0.42%
Top 10 Hldgs %
51.28%
Holding
86
New
9
Increased
45
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$49.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$40.7M
3
INCY icon
Incyte
INCY
+$26.8M
4
PTCT icon
PTC Therapeutics
PTCT
+$26.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$21.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$96M
2
PFE icon
Pfizer
PFE
+$53.7M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$46.4M
4
AGN
Allergan plc
AGN
+$36.3M
5
RLYP
RELYPSA INC COM
RLYP
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 97.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGN icon
26
Align Technology
ALGN
$12B
$25.4M 1.08%
386,104
-126,289
-25% -$8.1M
UNH icon
27
UnitedHealth
UNH
$379B
$24.7M 1.05%
209,648
+18,500
+10% +$2.16M
STJ
28
DELISTED
St Jude Medical
STJ
$24.5M 1.05%
397,161
+42,250
+12% +$2.66M
NBIX icon
29
Neurocrine Biosciences
NBIX
$17.7B
$23.6M 1.01%
+416,680
New +$21.2M
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$22.7M 0.97%
+288,906
New +$16.7M
TSRO
31
DELISTED
TESARO, Inc.
TSRO
$21.2M 0.9%
+405,069
New +$19.4M
TVRD
32
Tvardi Therapeutics
TVRD
$23.8M
$20.4M 0.87%
33,683
+5,258
+18% +$2.89M
EW icon
33
Edwards Lifesciences
EW
$47.8B
$19.8M 0.84%
750,885
-167,805
-18% -$4.36M
QURE icon
34
uniQure
QURE
$2.63B
$18.8M 0.8%
1,138,513
+376,600
+49% +$6.98M
TGTX icon
35
TG Therapeutics
TGTX
$8.53B
$18.2M 0.77%
1,521,667
+57,562
+4% +$727K
AIMT
36
DELISTED
Aimmune Therapeutics
AIMT
$18.1M 0.77%
982,133
+189,495
+24% +$3.51M
ADXS
37
DELISTED
Advaxis Inc
ADXS
$18M 0.77%
119,381
+35,153
+42% +$6.04M
IMDZ
38
DELISTED
Immune Design Corp.
IMDZ
$17.2M 0.73%
856,867
+11,000
+1% +$190K
ISRG icon
39
Intuitive Surgical
ISRG
$128B
$16.9M 0.72%
279,270
+62,406
+29% +$3.5M
NVO
40
Novo Nordisk
NVO
$220B
$16.1M 0.69%
554,150
+83,400
+18% +$2.31M
NXTM
41
DELISTED
NxStage Medical Inc.
NXTM
$15.4M 0.66%
701,303
-11,026
-2% -$205K
NVS icon
42
Novartis
NVS
$297B
$15.3M 0.65%
199,100
+36,940
+23% +$2.93M
SRRA
43
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$14.4M 0.61%
22,764
+1,195
+6% +$809K
SGNT
44
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$12.9M 0.55%
810,362
+224,703
+38% +$3.54M
TDOC icon
45
Teladoc Health
TDOC
$1.61B
$10.4M 0.44%
577,361
+159,661
+38% +$2.95M
HTWR
46
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$10.3M 0.44%
204,008
-20,572
-9% -$966K
ADPT
47
DELISTED
Adeptus Health Inc
ADPT
$10.2M 0.44%
+187,744
New +$12M
ACHC icon
48
Acadia Healthcare
ACHC
$2.99B
$9.92M 0.42%
158,852
+30,798
+24% +$2.01M
IONS icon
49
Ionis Pharmaceuticals
IONS
$9.25B
$9.29M 0.4%
+150,000
New +$8.09M
CI icon
50
Cigna
CI
$77B
$8.36M 0.36%
57,104
+1,200
+2% +$165K
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sectoral Asset Management held 86 positions worth $2.35B, up 7.4% from $2.18B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sectoral Asset Management's Q4 2015 filing shows 9 new, 45 increased, 20 reduced and 11 closed positions. Its largest new stake was Eli Lilly: 599,245 shares worth $50.5M. The largest sale was Biogen, an estimated $96M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier.

  • Sectoral Asset Management's largest Q4 2015 buy was Eli Lilly: 599,245 shares worth $50.5M.
  • Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q4 2015, an estimated $40.7M increase.
  • Sectoral Asset Management's biggest Q4 2015 reduction was Biogen, cutting an estimated $96M.
  • Sectoral Asset Management fully exited Pfizer in Q4 2015, selling an estimated $53.7M.
  • Sectoral Asset Management's ten largest holdings make up 51% of its $2.35B portfolio in Q4 2015.
  • Sectoral Asset Management opened 9 new positions and closed 11 in Q4 2015.
  • Sectoral Asset Management's portfolio value rose 7.4% quarter-over-quarter to $2.35B.

Based on Sectoral Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.